Literature DB >> 31094584

Therapeutic and cosmetic applications of mangiferin: an updated patent review (patents published after 2013).

Farha Quadri1, Manasi Telang1, Anita Mandhare1.   

Abstract

INTRODUCTION: Mangiferin and its derivatives possess diverse biological activities and desirable drug like properties. In continuation with the authors' previous publication, the present study reviews recently published patents in correlation with efforts of drug development using mangiferin. AREAS COVERED: Patents published after the year 2013 were analyzed for therapeutic and cosmetic applications of mangiferin, its salts, derivatives, and preparations. Patent information pertaining to improving solubility and bioavailability of mangiferin and related bioactives has also been presented. Methods of extraction of mangiferin and poly herbal preparations have not been included. Biological testing data has been put forth to understand the clinical trial status of products comprising mangiferin and/or its derivatives. EXPERT OPINION: Mangiferin has been highlighted as a multitarget bioactive with therapeutic potential. Research efforts in the recent years have contributed to development of new mangiferin derivatives as well as mangiferin formulations with enhanced solubility and bioavailability. Improvements in drug delivery systems for mangiferin might contribute to designing clinical trials to validate its therapeutic potential in humans. Majority of the recent patents have been filed by Chinese inventors claiming second medical use of mangiferin or its related compounds. However, a number of these patents remain in the prosecution stage.

Entities:  

Keywords:  Mangiferin; bioavailability; clinical trial; drug delivery; second medical use

Mesh:

Substances:

Year:  2019        PMID: 31094584     DOI: 10.1080/13543776.2019.1620205

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  3 in total

1.  Ionic liquids vs. ethanol as extraction media of algicidal compounds from mango processing waste.

Authors:  Mateus L Segatto; Lena Schnarr; Oliver Olsson; Klaus Kümmerer; Vania G Zuin
Journal:  Front Chem       Date:  2022-09-16       Impact factor: 5.545

2.  Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease.

Authors:  He Lin; Houlei Teng; Wei Wu; Yong Li; Guangfu Lv; Xiaowei Huang; Wenhao Yan; Zhe Lin
Journal:  BMC Pharmacol Toxicol       Date:  2020-08-06       Impact factor: 2.483

3.  Antiplatelet Activity of Natural Bioactive Extracts from Mango (Mangifera Indica L.) and its By-Products.

Authors:  María Elena Alañón; Iván Palomo; Lyanne Rodríguez; Eduardo Fuentes; David Arráez-Román; Antonio Segura-Carretero
Journal:  Antioxidants (Basel)       Date:  2019-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.